COMBINATION CHEMOTHERAPY WITH MITOMYCIN AND VINDESINE IN ADVANCED NON-SMALL CELL LUNG-CANCER - A PILOT-STUDY BY THE LUNG-CANCER WORKING PARTY (BELGIUM)

被引：0
|
作者：
SCULIER, JP
KLASTERSKY, J
DUMONT, JP
VANDERMOTEN, G
ROCMANS, P
LIBERT, P
RAVEZ, P
BECQUART, D
MOMMEN, P
DALESIO, O
机构：
[1] INST JULES BORDET, 1 RUE HEGER BORDET, B-1000 BRUSSELS, BELGIUM
[2] ACAD ZIEKENHUIS MIDDELHEIM, ANTWERPEN, BELGIUM
[3] ACAD ZIEKENHUIS ANTWERPEN, ANTWERPEN, BELGIUM
[4] HOP WARQUIGNIES, BOUSSU, BELGIUM
[5] HOP ERASME, BRUXELLES, BELGIUM
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The combination of mitomycin plus vindesine in advanced non-small cell lung cancer induced an objective response rate of 23% in 43 evaluable patients: 33% in nonpretreated patients (nine response among 27 patients) and 6% in pretreated patients (one response among 16 patients). Toxicity was tolerable. We conclude that the regimen was a moderately active and easy to administer treatment for advanced non-small cell lung cancer.
引用
收藏
页码：773 / 775
页数：3
相关论文
共 50 条
  • [41] PROGRESS IN CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER
    SCULIER, JP
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (11): : 1329 - 1333
  • [42] IS THERE STANDARD CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    ELLIOTT, JA
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (04): : 369 - 371
  • [43] CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER (NSCLC)
    THATCHER, N
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 886 - 887
  • [44] PREOPERATIVE CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    SPLINTER, TAW
    KHO, GS
    FREDERIKSZ, A
    CANCER DRUG DELIVERY, 1986, 3 (01): : 64 - 64
  • [45] VINDESINE - AN EFFECTIVE AGENT IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER
    FURNAS, BE
    WILLIAMS, SD
    EINHORN, LH
    COBLEIGH, MA
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1709 - 1711
  • [46] VINDESINE, CISPLATIN, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER - SURVIVAL AND QUALITY-OF-LIFE
    BAKKER, W
    VANOOSTEROM, AT
    AARONSON, NK
    VANBREUKELEN, FJM
    BINS, MC
    HERMANS, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 963 - 970
  • [47] CISPLATIN MITOMYCIN AND VINDESINE IN THE TREATMENT OF INOPERABLE NON-SMALL-CELL LUNG-CANCER
    THOMAS, P
    KLEISBAUER, JP
    PEROL, M
    TAYTARD, A
    POIRIER, R
    LECAER, H
    GUERIN, JC
    BONNAUD, F
    BALMES, P
    CARLES, P
    VERGERET, J
    CHAVAILLON, JM
    DEMUIZON, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) : 477 - 477
  • [48] CARBOPLATIN AND VINDESINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A FEASIBILITY STUDY
    TUCCI, E
    ALGERI, R
    TRUSSO, M
    PEPI, F
    SCHIAROLI, G
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (02) : 119 - 122
  • [49] COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINEDICHLOROPLATINUM AND VINBLASTINE IN ADVANCED NON-SMALL CELL LUNG-CANCER
    WOODCOCK, TM
    BLUMENREICH, MS
    RICHMAN, SP
    KUBOTA, TT
    GENTILE, PS
    ALLEGRA, JC
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (04) : 247 - 250
  • [50] THE EFFECTIVENESS OF COMBINATION CHEMOTHERAPY WITH CISPLATINUM AND ETOPOSIDE IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER
    GEBBIA, V
    PALMERI, S
    RUSSO, A
    GEBBIA, N
    RAUSA, L
    JOURNAL OF CHEMOTHERAPY, 1989, 1 (03) : 203 - 206
12345